Carbetocin Nasal Spray for Hunger in Prader-Willi Syndrome

We are studying the safety of carbetocin nasal spray for people with Prader-Willi Syndrome who experience uncontrollable hunger. The trial also looks at how this treatment may help with anxiety and caregiver challenges.

>2 years Confirmation phase (III)Post-Trial Drug Access No Placebo Investigational MedicinesEndocrinologyPediatrics

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Carbetocin

Carbetocin is a medicine used to prevent heavy bleeding after childbirth by helping the womb contract.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Carbetocin

Carbetocin is a substance that helps contract the uterus to prevent excessive bleeding after childbirth.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Carbetocin

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Carbetocin Aguettant

Carbetocin Auxilia

Carbetocin Mercapharm

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Centre Hospitalier Universitaire De Toulouse

Endocrinology Unit, Obesity, Bone Diseases, genetics and Medical Gynecology

Blagnac, France

KJF Klinik Josefinum gGmbH

Pediatrics and Adolescent Medicine

Augsburg, Germany

Universitaetsklinikum Essen AöR

Office Children’s Endocrinology

Essen, Germany

Sponsor: Acadia Pharmaceuticals Inc.

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.